Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Recent advances in hair loss treatments show significant progress.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

The new formulation improved the skin absorption of the drug Thiocolchicoside.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

The N-K GM Series offers a new method to reduce aflatoxin poisoning and cancer, improving health and saving costs in affected regions.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Strontium ranelate is no longer available for treatment.

Metformin can help diagnose and treat high testosterone levels in women, often due to insulin resistance rather than a tumor.

Trichodynia is a painful scalp condition needing targeted treatments beyond symptom management.

TRPV4 channels in the skin may enhance the effects of acupuncture.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

A new mutation in the TRPS1 gene caused Trichorhinophalangeal syndrome in a 17-year-old, highlighting the need for genetic testing.

The Itpr3 gene causes a specific hair pattern in mice.

The new fluoroquinolone effectively fights certain bacteria.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

Microbeam radiation therapy's dose distribution changes with depth.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

A benign skin tumor was removed from a man's leg, and it didn't come back after 9 months.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Accidental findings have led to new hair treatment discoveries, like using blood pressure and diabetes medications for hair loss and unwanted hair.

Iron deficiency is common in kidney transplant patients, and while iron treatment helps, it can cause high red blood cell levels.

The hydrogel effectively treats dental implant issues by killing bacteria, reducing inflammation, and improving implant success.